» Articles » PMID: 37108697

In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System As Measured by Fecal Adnab-9 Binding of P87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective...

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 28
PMID 37108697
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 severity predictions are feasible, though individual susceptibility is not. The latter prediction allows for planning vaccination strategies and the quarantine of vulnerable targets. Ironically, the innate immune response (InImS) is both an antiviral defense and the potential cause of adverse immune outcomes. The competition for iron has been recognized between both the immune system and invading pathogens and expressed in a ratio of ferritin divided by p87 (as defined by the Adnab-9 ELISA stool-binding optical density, minus the background), known as the FERAD ratio. Associations with the FERAD ratio may allow predictive modeling for the susceptibility and severity of disease. We evaluated other potential COVID-19 biomarkers prospectively. Patients with PCR+ COVID-19 tests (Group 1; n = 28) were compared to three other groups. In Group 2 (n = 36), and 13 patients displayed COVID-19-like symptoms but had negative PCR or negative antibody tests. Group 3 (n = 90) had no symptoms and were negative when routinely PCR-tested before medical procedures. Group 4 (n = 2129) comprised a pool of patients who had stool tests and symptoms, but their COVID-19 diagnoses were unknown; therefore, they were chosen to represent the general population. Twenty percent of the Group 4 patients (n = 432) had sufficient data to calculate their FERAD ratios, which were inversely correlated with the risk of COVID-19 in the future. In a case report of a neonate, we studied three biomarkers implicated in COVID-19, including p87, Src (cellular-p60-sarcoma antigen), and Abl (ABL-proto-oncogene 2). The InImS of the first two were positively correlated. An inverse correlation was found between ferritin and lysozyme in serum ( < 0.05), suggesting that iron could have impaired an important innate immune system anti-viral effector and could partially explain future COVID-19 susceptibility.

Citing Articles

Predicting Regression of Barrett's Esophagus-Can All the King's Men Put It Together Again?.

Tobi M, Khoury N, Al-Subee O, Sethi S, Talwar H, Kam M Biomolecules. 2024; 14(9).

PMID: 39334948 PMC: 11430295. DOI: 10.3390/biom14091182.


The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9.

Tobi M, Antaki F, Rambus M, Yang Y, Kaplan D, Rodriguez R Int J Mol Sci. 2023; 24(24).

PMID: 38139086 PMC: 10743815. DOI: 10.3390/ijms242417257.


Status May Differentiate Two Distinct Pathways of Gastric Adenocarcinoma Carcinogenesis.

Tobi M, Weinstein D, Kim M, Hatfield J, Sochacki P, Levi E Curr Oncol. 2023; 30(9):7950-7963.

PMID: 37754493 PMC: 10527591. DOI: 10.3390/curroncol30090578.

References
1.
Abassi Z, Knaney Y, Karram T, Heyman S . The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?. Front Immunol. 2020; 11:1312. PMC: 7291598. DOI: 10.3389/fimmu.2020.01312. View

2.
Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M . The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020; 5(10). PMC: 7259533. DOI: 10.1172/jci.insight.137799. View

3.
Cohn S . The Dramaturgy of Epidemics. Bull Hist Med. 2021; 94(4):578-589. DOI: 10.1353/bhm.2020.0083. View

4.
Evans C, Bowen J . Immunological tests in carcinoma of the prostate. Proc R Soc Med. 1977; 70(6):417-20. PMC: 1543187. View

5.
Yang A, Liu J, Tao W, Li H . The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020; 84:106504. PMC: 7152924. DOI: 10.1016/j.intimp.2020.106504. View